, June 27 -- Trading in the Global Depository Receipts (GDRs) of BEXIMCO Pharmaceuticals PLC on the London Stock Exchange (LSE) has resumed from June 26, after the bourse lifted its trading suspension following coordinated intervention by the DSE Brokers Association of Bangladesh (DBA).

BEXIMCO Pharmaceuticals PLC is the only Bangladeshi company listed on the LSE, having secured its listing in 2004. The company's GDR trading was suspended from January 2, 2026, after it failed to publish its audited financial statements for the year ended June 30, 2025, and subsequent financial disclosures within the required timeframe.

Under LSE listing rules, any security suspended continuously for six months without resolution of the suspension ground...